Xavical Softgel Capsule is a combination pharmaceutical formulation containing Calcitriol (0.25 mcg), Calcium Carbonate (500 mg), and Zinc Sulfate (7.5 mg), designed to support bone health and mineral metabolism. Calcitriol, the active form of vitamin D3, plays a critical role in enhancing intestinal absorption of calcium and phosphate, thereby aiding in the regulation of calcium homeostasis and promoting bone mineralization. Calcium Carbonate serves as a vital calcium supplement, essential for maintaining adequate calcium levels in the body, which is crucial for bone strength, neuromuscular function, and cardiovascular health. Zinc Sulfate contributes to the overall efficacy of the formulation by supporting enzymatic functions, immune response, and tissue repair, which are important in bone remodeling and healing processes. Xavical Softgel Capsule is indicated for the prevention and treatment of conditions such as osteoporosis, hypocalcemia, and other calcium or vitamin D deficiencies. It is particularly beneficial in patients with impaired calcium absorption, chronic kidney disease, or those requiring supplementation due to dietary insufficiency. The softgel formulation ensures ease of administration and improved bioavailability. Use of Xavical should be under medical supervision, with monitoring of serum calcium levels to avoid hypercalcemia and other potential adverse effects.